Back to results
US 2025/0188103 A1Published application
Heterocyclic glp-1 agonists
AssigneeGasherbrum Bio, Inc.
InventorsXichen LIN, Qinghua MENG, Weiqiang XING, Zhongmiao XU
Life of this patent
Estimating the term…
Abstract
This disclosure relates to GLP-1 agonists, pharmaceutical compositions, and methods of use thereof.
Claims36
A compound of Formula I:
- or a pharmaceutically acceptable salt, deuterated analog, or solvate thereof, wherein:
- X is C and Y is N, or Y is C and X is N and the dashed lines represent an optional bond such that the moiety
- is
- where bond y is attached to Y and bond x is attached to X;
- Ring A is C6-10 aryl, C5-10 cycloalkyl, 5-10 membered heterocyclyl, or 5-10 membered heteroaryl, each of which is optionally substituted with from 1-5 substituents each independently selected from the group consisting of halo, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, and C3-6 cycloalkyl;
- R1, R2, and R3 are each independently selected from the group consisting of H and C1-6 alkyl which is optionally substituted with from 1-6 substituents each independently selected from the group consisting of halo, —OH, and C1-6 alkoxy;
- L1 is selected from the group consisting of —C(═O)—, —CH2—, —CH(C1-6 alkyl)-, and —S(═O)2;
- Ring B is selected from the group consisting of
- wherein bb represents point of attachment to L1;
- R4, R5, R6, and R7 are independently selected from the group consisting of H, halo, and C1-6 alkyl;
- L3 is a bond or C1-3 alkylene;
- L4 is a bond or C1-5 alkylene;
- R8a and R8b are independently selected from the group consisting of H and C1-6 alkyl optionally substituted with one or more substituents independently selected from the group consisting of halo and C3-15 cycloalkyl;
- or R8a and R8b taken together with the carbon atom to which each is attached forms a C3-15 cycloalkyl ring which is optionally substituted with from 1-3 independently selected C1-6 alkyl, wherein the C1-6 alkyl is optionally substituted with from 1-6 independently selected from Rf;
- or the moiety -L3-C(R8aR8b)-L4-R9 is a phenyl substituted with C(═O)OH, and optionally 1-4 additional substituents independently selected from Rf;
- R9 is selected from the group consisting of C(═O)OH, C(═O)(OC1-6 alkyl), C(═O)NR9aR9b, (IX-1), (IX-2), (IX-3), and (IX-4):
- R9a is H or C1-6 alkyl;
- R9b is H, C1-6 alkyl, C(═O)(C1-6 alkyl), S(O)0-2(C1-6 alkyl), or cyano;
- R9c, R9d, R9e, R9f, and R9g are each independently selected from the group consisting of H, C1-6 alkyl optionally substituted with from 1-6 independently selected halo and C1-6 alkoxy, and C(═O)(C1-6 alkyl);
- Ring C is selected from the group consisting of 3-12 membered heterocyclyl, C3-15 cycloalkyl, and 5-10 membered heteroaryl, each of which is optionally substituted with from 1-3 RCa;
- each RCa is independently selected from the group consisting of halo, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, and NRcRd;
- or a pair of RCa on the same or different ring atoms, taken together with the ring atom(s) to which each is attached, forms a carbocyclic ring including from 3-8 ring atoms;
- L2 is selected from the group consisting of
- wherein aa represents the point of attachment to Q;
- n1 is an integer from 1-3;
- L2A is a bond or C1-10 alkylene;
- RLa is selected from the group consisting of H, C1-6 alkyl, and C(═O)(C1-6 alkyl);
- each of RLb and RLc is independently selected from the group consisting of H and C1-6 alkyl;
- Q is selected from the group consisting of C1-10 alkyl;
- C3-15 cycloalkyl;
- 3-12 membered heterocyclyl;
- 5-10 membered heteroaryl;
- and C6-10 aryl, wherein Q is substituted with —P(═O)RaRb, and optionally substituted with from 1-6 additional substituents independently selected from RQ;
- each RQ is independently selected from the group consisting of
- (a) halo;
- (b) cyano;
- (c) OH or oxo;
- (d) —NRcRd;
- (e) —C(═O)NRcRd or —S(O)2NRcRd;
- (f) —S(═O)0-2Re;
- (g) C1-6 alkyl optionally substituted with from 1-6 independently selected Rf;
- (h) C1-6 alkoxy optionally substituted with from 1-6 independently selected Rf;
- (i) 3-12 membered heterocyclyl optionally substituted with from 1-6 independently selected Rg;
- (j) C6-10 aryl optionally substituted with from 1-6 independently selected Rg;
- (k) 5-10 membered heteroaryl optionally substituted with from 1-6 independently selected Rg;
- (l) C3-8 cycloalkyl optionally substituted with from 1-6 independently selected Rg;
- (in) —P(═O)RaRb;
- and
- (n) —(CRhRh)q1—S(O)2-Le-Re, wherein q1 is 1, 2, or 3;
- or Q is C3-15 cycloalkyl;
- 3-12 membered heterocyclyl;
- 5-10 membered heteroaryl;
- and C6-10 aryl, each of which is optionally substituted with from 1-6 substituents each independently selected from the group consisting of RQA and RQB;
- provided that one or both of (aa) or (bb) applies:
- (aa) Q is substituted with at least one RQB;
- or
- (bb) Q is 4-12 membered heterocyclyl or 7-10 membered bicyclic heteroaryl, wherein Q comprises an endocyclic S(O)2 group;
- each RQA is independently selected from the group consisting of
- (a) halo;
- (b) cyano;
- (c) OH or oxo;
- (d) —NRaRb;
- (e) —C(═O)NRcRd;
- (f) C1-6 alkyl optionally substituted with from 1-6 independently selected Rf;
- (g) C1-6 alkoxy optionally substituted with from 1-6 independently selected Rf;
- (h) 3-12 membered heterocyclyl optionally substituted with from 1-6 independently selected Rg;
- (i) C6-10 aryl optionally substituted with from 1-6 independently selected Rg;
- (j) 5-10 membered heteroaryl optionally substituted with from 1-6 independently selected Rg;
- and
- (k) C3-8 cycloalkyl optionally substituted with from 1-6 independently selected Rg;
- each RQB is independently selected from the group consisting of:
- (a) -La-S(O)2-Lb-Re;
- and
- (b) 4-12 membered heterocyclyl or 7-10 membered bicyclic heteroaryl, each of which comprises an endocyclic S(O)2 group, wherein the heterocyclyl or heteroaryl is optionally substituted with from 1-6 independently selected Rg;
- La is selected from the group consisting of —N(H)—, —N(Rc)—, and —(CRhRh)q1;
- Lb is selected from the group consisting of —O—, —N(H)—, —N(Rc)—, and —(CRhRh)q2—;
- q1 and q2 are independently 0, 1, 2, 3, or 4;
- provided that when La is —(CRhRh)q1— and q1 is 0, then -Lb-Re is other than unsubstituted C1-3 alkyl;
- Ra and Rb are independently selected from the group consisting of C1-6 alkyl which is optionally substituted with from 1-6 substituents each independently selected from the group consisting of C1-6 alkoxy, C3-6 cycloalkyl, and halo;
- C3-6 cycloalkyl optionally substituted with from 1-3 substituents each independently selected from the group consisting of C1-3 alkyl and halo;
- and C6-10 aryl optionally substituted with from 1-3 independently selected C1-3 alkyl;
- or
- Ra and Rb taken together with the phosphorous atom to which each is attached forms a ring including from 5-8 ring atoms, wherein from 0-2 ring atoms (in addition to the phosphorous attached to Ra and Rb) are heteroatoms each independently selected from the group consisting of O, S, and N, wherein the ring is optionally substituted with from 1-3 independently selected C1-6 alkyl;
- each Rc and Rd are independently selected from the group consisting of H, C1-6 alkyl, C3-6 cycloalkyl, C(═O)(C1-6 alkyl), C(═O)(C3-6 cycloalkyl), C(═O)O(C1-6 alkyl), S(O)1-2(C1-6 alkyl), and S(O)1-2(C3-6 cycloalkyl), wherein the C1-6 alkyl, C(═O)(C1-6 alkyl), C(═O)(C3-6 cycloalkyl), C(═O)O(C1-6 alkyl), S(O)1-2(C1-3alkyl), and S(O)1-2(C3-6 cycloalkyl) are each optionally substituted with from 1-6 substituents independently selected from the group consisting of —OH, halo, and C1-6 alkoxy;
- Re is H, or Rc is selected from the group consisting of C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, C3-6 cycloalkyl, and 3-8 membered heterocyclyl, each of which is optionally substituted with from 1-3 substituents each independently selected from the group consisting of halo, cyano, C1-3 alkyl, C1-3 haloalkyl, —OH, NH2, NH(C1-3 alkyl), N(C1-3 alkyl)2, C1-3 alkoxy, and C1-3 haloalkoxy;
- Le is a bond, NRc, or O;
- each Rf is independently selected from the group consisting of halo, —OH, NRcRd, C1-6 alkoxy, C1-6 haloalkoxy, and 3-12 membered heterocyclyl which is optionally substituted with from 1-4 substituents each independently selected from the group consisting of —OH, C1-6 alkyl, and 3-12 membered heterocyclyl;
- each Rg is independently selected from the group consisting of C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, NRcRd, cyano, halo, C3-6 cycloalkyl, and 3 to 12 membered heterocyclyl optionally substituted with one or more substituents each independently selected from the group consisting of C1-6 alkyl and C(═O)C1-6 alkyl;
- and
- each occurrence of Rh is independently selected from the group consisting of H, C1-6 alkyl, C1-6 haloalkyl, C3-6 cycloalkyl, and halo;
- or
- a pair of Rh on the same or different carbon atom(s), taken together with the carbon atom(s) connecting them forms C3-6 cycloalkyl or 4-8 membered heterocyclyl, each of which is optionally substituted with from 1-3 substituents each independently selected from the group consisting of halo, cyano, C1-3 alkyl, C1-3 haloalkyl, —OH, C1-3 alkoxy, and C1-3 haloalkoxy.
89 more elements
A compound of Formula II:
- or a pharmaceutically acceptable salt thereof or a solvate thereof, wherein:
- Q1, Q2, Q3, Q4, and Q5 are defined according to (AA) or (BB) below:
- (AA)
- Q1 and Q5 are independently selected from the group consisting of N, CH, and CRQC;
- Q2, Q3, and Q4 are independently selected from the group consisting of N, CH, CRQC, and CRQD, provided that at least one of Q2, Q3, and Q4 is CRQD;
- each is a single bond or double bond, provided that the ring including Q1-Q5 is aromatic;
- (BB)
- Q1 is a bond;
- Q2, Q3, Q4, and Q5 are independently selected from the group consisting of O, S, N, NH, NRc, CH, CRQC, and CRQD, provided that at least one of Q2, Q3, Q4, and Q5 is CRQD;
- each is a single bond or double bond, provided that the ring including Q1-Q5 is aromatic;
- RQD is P(═O)RaRb, wherein Ra and Rb are independently selected from the group consisting of C1-6 alkyl which is optionally substituted with from 1-6 substituents each independently selected from the group consisting of C1-6 alkoxy, C3-6 cycloalkyl, and halo;
- C3-6 cycloalkyl optionally substituted with from 1-3 substituents each independently selected from the group consisting of C1-3 alkyl and halo;
- and C6-10 aryl optionally substituted with from 1-3 independently selected C1-3 alkyl;
- or
- Ra and Rb taken together with the phosphorous atom to which each is attached forms a ring including from 5-8 ring atoms, wherein from 0-2 ring atoms (in addition to the phosphorous attached to Ra and Rb) are heteroatoms each independently selected from the group consisting of O, S, and N, wherein the ring is optionally substituted with from 1-3 independently selected C1-6 alkyl;
- each RQC is independently selected from the group consisting of (a) halo;
- (b) cyano;
- (c) OH;
- (d) —NRcRd;
- (e) C(═O)NRcRd;
- (f) S(═O)0-2Re;
- (g) C1-6 alkyl optionally substituted with from 1-6 independently selected Rf;
- (h) C1-6 alkoxy optionally substituted with from 1-6 substituents each independently selected from the group consisting of hydroxy, halo, and C1-6 alkoxy;
- (i) 3-12 membered heterocyclyl optionally substituted with one or more substituents each independently selected from the group consisting of C1-6 alkyl and C(═O)(C1-6 alkyl);
- (j) C6-10 aryl optionally substituted with from 1-3 independently selected C(═O)(C1-6 alkyl);
- and (k) 5-10 membered heteroaryl optionally substituted with from 1-6 independently selected Rg;
- or a pair of RQC on adjacent carbon atoms, taken together with the atom to which each is attached, forms a ring including from 5-8 ring atoms, wherein from 0-2 ring atoms are heteroatoms each independently selected from the group consisting of O, N, and S, wherein said ring is optionally substituted with from 1-2 independently selected R groups;
- L2 is selected from the group consisting of
- wherein aa represents the point of attachment to the ring containing Q1-Q5;
- n1 is an integer from 1-3;
- L2A is a bond or C1-10 alkylene;
- RLa is selected from the group consisting of H, C1-6 alkyl, and C(═O)(C1-6 alkyl);
- each of RLb and RLC is independently selected from the group consisting of H and C1-6 alkyl;
- Ring A is C6-10 aryl, C5-7 cycloalkyl, 5-7 membered heterocyclyl, or 5-10 membered heteroaryl, each of which is optionally substituted with from 1-5 substituents each independently selected from the group consisting of halo, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, and C3-6 cycloalkyl;
- R1, R2, and R3 are each independently selected from the group consisting of H and C1-6 alkyl which is optionally substituted with from 1-6 substituents each independently selected from the group consisting of halo, —OH, and C1-6 alkoxy;
- L1 is selected from the group consisting of —C(═O)—, —CH2—, —CH(C1-6 alkyl)-, and —S(═O)2;
- Ring B is selected from the group consisting of
- wherein bb represents point of attachment to L1;
- R4, R5, R6, and R7 are independently selected from the group consisting of H, halo, and C1-6 alkyl;
- L3 is a bond or C1-3 alkylene;
- L4 is a bond or C1-5 alkylene;
- R8a and R8b are independently selected from the group consisting of H and C1-6 alkyl optionally substituted with one or more substituents independently selected from the group consisting of halo and C3-15 cycloalkyl;
- or
- R8a and R8b taken together with the carbon atom to which each is attached forms a C3-15 cycloalkyl ring which is optionally substituted with from 1-3 independently selected C1-6 alkyl, wherein the C1-6 alkyl is optionally substituted with from 1-6 independently selected Rf;
- R9 is selected from the group consisting of C(═O)OH, C(═O)(OC1-6 alkyl), C(═O)NR9aR9b, (IX-1), (IX-2), (IX-3), and (IX-4):
- R9a is H or C1-6 alkyl;
- R9b is H, C1-6 alkyl, C(═O)(C1-6 alkyl), S(O)0-2(C1-6 alkyl), or cyano;
- R9c, R9d, R9e, R9f, and R9g are each independently selected from the group consisting of H;
- C1-6 alkyl optionally substituted with from 1-6 independently selected halo and C1-6 alkoxy;
- and C(═O)(C1-6 alkyl);
- Ring C is selected from the group consisting of 3-12 membered heterocyclyl;
- C3-15 cycloalkyl;
- and 5-10 membered heteroaryl, each of which is optionally substituted with from 1-3 RCa;
- each RCa is independently selected from the group consisting of halo, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, and NRcRd;
- or a pair of RCa on the same or different ring atoms, taken together with the ring atom(s) to which each is attached, forms a carbocyclic ring including from 3-8 ring atoms;
- each Rc and Rd are independently selected from the group consisting of H, C1-6 alkyl, C(═O)(C1-6 alkyl), C(═O)(C3-6 cycloalkyl), C(═O)O(C1-6 alkyl), S(O)1-2(C1-6 alkyl), and S(O)1-2(C3-6 cycloalkyl), wherein the C1-6 alkyl, C(═O)(C1-6 alkyl), C(═O)(C3-6 cycloalkyl), C(═O)O(C1-6 alkyl), S(O)1-2(C1-6 alkyl), and S(O)1-2(C3-6 cycloalkyl) are each optionally substituted with from 1-6 substituents independently selected from the group consisting of —OH, halo, and C1-6 alkoxy;
- Rc is H, C1-6 alkyl, or C1-6 haloalkyl;
- each Rf is independently selected from the group consisting of halo, —OH, NRcRd, C1-6 alkoxy, C1-6 haloalkoxy, and 3-12 membered heterocyclyl which is optionally substituted with from 1-4 substituents each independently selected from the group consisting of —OH, C1-6 alkyl, and 3-12 membered heterocyclyl;
- each Rg is independently selected from the group consisting of C1-6 alkyl, C1-6 alkoxy, NRcRd, and 3 to 12 membered heterocyclyl optionally substituted with one or more substituents each independently selected from the group consisting of C1-6 alkyl and C(═O)C1-6 alkyl;
- and
- each Rh is independently selected from the group consisting of halo, cyano, C1-6 alkyl, C1-6 haloalkyl, —OH, NH2, NH(C1-3 alkyl), N(C1-3 alkyl)2, C1-3 alkoxy, and C1-3 haloalkoxy.
58 more elements
A compound of Formula III:
- or a pharmaceutically acceptable salt, deuterated analog, or solvate thereof, wherein:
- Ring D is selected from the group consisting of C3-15 cycloalkyl;
- 3-12 membered heterocyclyl;
- 5-10 membered heteroaryl;
- and C6-10 aryl, each of which is optionally substituted with from 1-6 substituents each independently selected from the group consisting of RQA and RQB;
- provided that one or both of (aa) or (bb) applies:
- (aa) Ring D is substituted with at least one RQB;
- or
- (bb) Ring D is 4-12 membered heterocyclyl or 7-10 membered bicyclic heteroaryl, wherein Ring D comprises an endocyclic S(O)2 group;
- each RQA is independently selected from the group consisting of
- (a) halo;
- (b) cyano;
- (c) OH or oxo;
- (d) —NRaRb;
- (e) —C(═O)NRcRd;
- (f) C1-6 alkyl optionally substituted with from 1-6 independently selected Rf;
- (g) C1-6 alkoxy optionally substituted with from 1-6 independently selected Rf;
- (h) 3-12 membered heterocyclyl optionally substituted with from 1-6 independently selected Rg;
- (i) C6-10 aryl optionally substituted with from 1-6 independently selected Rg;
- (j) 5-10 membered heteroaryl optionally substituted with from 1-6 independently selected Rg;
- and
- (k) C3-8 cycloalkyl optionally substituted with from 1-6 independently selected Rg;
- each RQB is independently selected from the group consisting of
- (a) -La-S(O)2-Lb-Re;
- and
- (b) 4-12 membered heterocyclyl or 7-10 membered bicyclic heteroaryl, each of which comprises an endocyclic S(O)2 group, wherein the heterocyclyl or heteroaryl is optionally substituted with from 1-6 independently selected Rg;
- La is selected from the group consisting of —N(H)—, —N(Rc)—, and —(CRhRh)q1;
- Lb is selected from the group consisting of —O—, —N(H)—, —N(Rc)—, and —(CRhRh)q2—;
- q1 and q2 are independently 0, 1, 2, 3, or 4;
- provided that when La is —(CRhRh)q1— and q1 is 0, then -Lb-Re is other than unsubstituted C1-3 alkyl;
- L2 is selected from the group consisting of
- wherein aa represents the point of attachment to Ring D;
- n1 is an integer from 1-3;
- L2A is a bond or C1-10 alkylene;
- RLa is selected from the group consisting of H, C1-6 alkyl, and C(═O)(C1-6 alkyl);
- each of RLb and RLc is independently selected from the group consisting of H and C1-6 alkyl;
- Ring A is C6-10 aryl, C5-10 cycloalkyl, 5-10 membered heterocyclyl, or 5-10 membered heteroaryl, each of which is optionally substituted with from 1-5 substituents each independently selected from the group consisting of halo, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, and C3-6 cycloalkyl;
- R1, R2, and R3 are each independently selected from the group consisting of H and C1-6 alkyl which is optionally substituted with from 1-6 substituents each independently selected from the group consisting of halo, —OH, and C1-6 alkoxy;
- L1 is selected from the group consisting of —C(═O)—, —CH2—, —CH(C1-6 alkyl)-, and —S(═O)2;
- Ring B is selected from the group consisting of
- wherein bb represents point of attachment to L1;
- R4, R5, R6, and R7 are independently selected from the group consisting of H, halo, and C1-6 alkyl;
- L3 is a bond or C1-3 alkylene;
- L4 is a bond or C1-5 alkylene;
- R8a and R8b are independently selected from the group consisting of H and C1-6 alkyl optionally substituted with one or more substituents independently selected from the group consisting of halo and C3-15 cycloalkyl;
- or
- R8a and R8b taken together with the carbon atom to which each is attached forms a C3-15 cycloalkyl ring which is optionally substituted with from 1-3 independently selected C1-6 alkyl, wherein the C1-6 alkyl is optionally substituted with from 1-6 independently selected Rf;
- R9 is selected from the group consisting of C(═O)OH, C(═O)(OC1-6 alkyl), C(═O)NR9aR9b(IX-1), (IX-2), (IX-3), and (IX-4):
- R9a is H or C1-6 alkyl;
- R9b is H, C1-6 alkyl, C(═O)(C1-6 alkyl), S(O)0-2(C1-6 alkyl), or cyano;
- R9c, R9d, R9e, R9f, and R9g are each independently selected from the group consisting of H;
- C1-6 alkyl optionally substituted with from 1-6 independently selected halo and C1-6 alkoxy;
- and C(═O)(C1-6 alkyl);
- Ring C is selected from the group consisting of 3-12 membered heterocyclyl;
- C3-15 cycloalkyl;
- and 5-10 membered heteroaryl, each of which is optionally substituted with from 1-3 RCa;
- each RCa is independently selected from the group consisting of halo, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, and NRcRd;
- or a pair of RCa on the same or different ring atoms, taken together with the ring atom(s) to which each is attached, forms a carbocyclic ring including from 3-8 ring atoms;
- each Ra and Rb are independently selected from the group consisting of H, C1-6 alkyl, C3-6 cycloalkyl, C(═O)(C1-6 alkyl), C(═O)(C3-6 cycloalkyl), and C(═O)O(C1-6 alkyl), wherein the C1-6 alkyl, C3-6 cycloalkyl, C(═O)(C1-6 alkyl), C(═O)(C3-6 cycloalkyl), and C(═O)O(C1-6 alkyl) are each optionally substituted with from 1-6 substituents independently selected from the group consisting of —OH, halo, and C1-6 alkoxy;
- each Rc and Rd are independently selected from the group consisting of H, C1-6 alkyl, C3-6 cycloalkyl, C(═O)(C1-6 alkyl), C(═O)(C3-6 cycloalkyl), C(═O)O(C1-6 alkyl), S(O)1-2(C1-6 alkyl), and S(O)1-2(C3-6 cycloalkyl), wherein the C1-6 alkyl, C3-6 cycloalkyl, C(═O)(C1-6 alkyl), C(═O)(C3-6 cycloalkyl), C(═O)O(C1-6 alkyl), S(O)1-2(C1-6 alkyl), and S(O)1-2(C3-6 cycloalkyl) are each optionally substituted with from 1-6 substituents independently selected from the group consisting of —OH, halo, and C1-6 alkoxy;
- Re is H, or Re is selected from the group consisting of C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, C3-6 cycloalkyl, and 3-8 membered heterocyclyl, each of which is optionally substituted with from 1-3 substituents each independently selected from the group consisting of halo, cyano, C1-3 alkyl, C1-3 haloalkyl, —OH, NH2, NH(C1-3 alkyl), N(C1-3 alkyl)2, C1-3 alkoxy, and C1-3 haloalkoxy;
- each Rf is independently selected from the group consisting of halo, —OH, NRcRd, C1-6 alkoxy, C1-6 haloalkoxy, and 3-12 membered heterocyclyl which is optionally substituted with from 1-4 substituents each independently selected from the group consisting of —OH, C1-6 alkyl, and 3-12 membered heterocyclyl;
- each Rg is independently selected from the group consisting of C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, NRcRd, cyano, halo, C3-6 cycloalkyl, and 3 to 12 membered heterocyclyl optionally substituted with one or more substituents each independently selected from the group consisting of C1-6 alkyl and C(═O)C1-6 alkyl;
- and
- each occurrence of Rh is independently selected from the group consisting of H, C1-6 alkyl, C1-6 haloalkyl, C3-6 cycloalkyl, and halo;
- or
- a pair of Rh on the same or different carbon atom(s), taken together with the carbon atom(s) connecting them forms C3-6 cycloalkyl or 4-8 membered heterocyclyl, each of which is optionally substituted with from 1-3 substituents each independently selected from the group consisting of halo, cyano, C1-3 alkyl, C1-3 haloalkyl, —OH, C1-3 alkoxy, and C1-3 haloalkoxy.
64 more elements
A compound of Formula IV:
- or a pharmaceutically acceptable salt, deuterated analog, or solvate thereof, wherein:
- Ring A is C6-10 aryl, C5-10 cycloalkyl, 5-10 membered heterocyclyl, or 5-10 membered heteroaryl, each of which is optionally substituted with from 1-5 substituents each independently selected from the group consisting of halo, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, and C3-6 cycloalkyl;
- R1, R2, and R3 are each independently selected from the group consisting of H and C1-6 alkyl which is optionally substituted with from 1-6 substituents each independently selected from the group consisting of halo, —OH, and C1-6 alkoxy;
- L1 is selected from the group consisting of —C(═O)—, —CH2—, —CH(C1-6 alkyl)-, and —S(═O)2;
- Ring B is selected from the group consisting of
- wherein bb represents point of attachment to L1;
- R4, R5, R6, and R7 are independently selected from the group consisting of H, halo, and C1-6 alkyl;
- L3 is a bond or C1-3 alkylene;
- L4 is a bond or C1-5 alkylene;
- R8a and R8b are independently selected from the group consisting of H and C1-6 alkyl optionally substituted with one or more substituents independently selected from the group consisting of halo and C3-15 cycloalkyl;
- or
- R8a and R8b taken together with the carbon atom to which each is attached forms a C3-15 cycloalkyl ring which is optionally substituted with from 1-3 independently selected C1-6 alkyl, wherein the C1-6 alkyl is optionally substituted with from 1-6 independently selected Rf;
- R9 is selected from the group consisting of C(═O)OH, C(═O)(OC1-6 alkyl), C(═O)NR9aR9b, (IX-1), (IX-2), (IX-3), and (IX-4):
- R9a is H or C1-6 alkyl;
- R9b is H, C1-6 alkyl, C(═O)(C1-6 alkyl), S(O)0-2(C1-6 alkyl), or cyano;
- R9c, R9d, R9e, R9f, and R9g are each independently selected from the group consisting of H;
- C1-6 alkyl optionally substituted with from 1-6 independently selected halo and C1-6 alkoxy;
- and C(═O)(C1-6 alkyl);
- Ring C is selected from the group consisting of 3-12 membered heterocyclyl;
- C3-10 cycloalkyl;
- and 5-10 membered heteroaryl, each of which is optionally substituted with from 1-3 RCa;
- each RCa is independently selected from the group consisting of halo, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, and NRcRd;
- or a pair of RCa on the same or different ring atoms, taken together with the ring atom(s) to which each is attached, forms a carbocyclic ring including from 3-8 ring atoms;
- L2 is selected from the group consisting of
- wherein aa represents the point of attachment to Q;
- n1 is an integer from 1-3;
- L2A is a bond or C1-10 alkylene;
- RLa is selected from the group consisting of H, C1-6 alkyl, and C(═O)(C1-6 alkyl);
- each of RLb and RLc is independently selected from the group consisting of H and C1-6 alkyl;
- Q is selected from the group consisting of C1-10 alkyl;
- C3-15 cycloalkyl;
- 3-12 membered heterocyclyl;
- 5-10 membered heteroaryl;
- and C6-10 aryl, each of which is optionally substituted with from 1-6 independently selected RQ;
- each RQ is independently selected from the group consisting of
- (a) halo;
- (b) cyano;
- (c) OH or oxo;
- (d) —NRcRd;
- (e) —C(═O)NRcRd or —S(O)2NRcRd;
- (f) —S(═O)0-2Re;
- (g) C1-6 alkyl optionally substituted with from 1-6 independently selected Rf;
- (h) C1-6 alkoxy optionally substituted with from 1-6 independently selected Rf;
- (i) 3-12 membered heterocyclyl optionally substituted with from 1-6 independently selected Rg;
- (j) C6-10 aryl optionally substituted with from 1-6 independently selected Rg;
- (k) 5-10 membered heteroaryl optionally substituted with from 1-6 independently selected Rg;
- (l) C3-8 cycloalkyl optionally substituted with from 1-6 independently selected Rg;
- (m) P(═O)RaRb;
- and
- (n) —(CRhRh)qS(O)2-Le-Re, wherein q1 is 1, 2, or 3;
- Ra and Rb are independently selected from the group consisting of C1-6 alkyl which is optionally substituted with from 1-6 substituents each independently selected from the group consisting of C1-6 alkoxy, C3-6 cycloalkyl, and halo;
- C3-6 cycloalkyl optionally substituted with from 1-3 substituents each independently selected from the group consisting of C1-3 alkyl and halo;
- and C6-10 aryl optionally substituted with from 1-3 independently selected C1-3 alkyl;
- or
- Ra and Rb taken together with the phosphorous atom to which each is attached forms a ring including from 5-8 ring atoms, wherein from 0-2 ring atoms (in addition to the phosphorous attached to Ra and Rb) are heteroatoms each independently selected from the group consisting of O, S, and N, wherein the ring is optionally substituted with from 1-3 independently selected C1-6 alkyl;
- each Rc and Rd are independently selected from the group consisting of H, C1-6 alkyl, C3-6 cycloalkyl, C(═O)(C1-6 alkyl), C(═O)(C3-6 cycloalkyl), C(═O)O(C1-6 alkyl), S(O)1-2(C1-6 alkyl), and S(O)1-2(C3-6 cycloalkyl), wherein the C1-6 alkyl, C(═O)(C1-6 alkyl), C(═O)(C3-6 cycloalkyl), C(═O)O(C1-6 alkyl), S(O)1-2(C1-6 alkyl), and S(O)1-2(C3-6 cycloalkyl) are each optionally substituted with from 1-6 substituents independently selected from the group consisting of —OH, halo, and C1-6 alkoxy;
- Re is H, or Re is selected from the group consisting of C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, C3-6 cycloalkyl, and 3-8 membered heterocyclyl, each of which is optionally substituted with from 1-3 substituents each independently selected from the group consisting of halo, cyano, C1-3 alkyl, C1-3 haloalkyl, —OH, NH2, NH(C1-3 alkyl), N(C1-3 alkyl)2, C1-3 alkoxy, and C1-3 haloalkoxy;
- Le is a bond, NRc, or O;
- each Rf is independently selected from the group consisting of halo, —OH, NRcRd, C1-6 alkoxy, C1-6 haloalkoxy, and 3-12 membered heterocyclyl which is optionally substituted with from 1-4 substituents each independently selected from the group consisting of —OH, C1-6 alkyl, and 3-12 membered heterocyclyl;
- each Rg is independently selected from the group consisting of C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, NRcRd, cyano, halo, C3-6 cycloalkyl, and 3 to 12 membered heterocyclyl optionally substituted with one or more substituents each independently selected from the group consisting of C1-6 alkyl and C(═O)C1-6 alkyl;
- and
- each occurrence of Rh is independently selected from the group consisting of H, C1-6 alkyl, C1-6 haloalkyl, C3-6 cycloalkyl, and halo;
- or
- a pair of Rh on the same or different carbon atom(s), taken together with the carbon atom(s) connecting them forms C3-6 cycloalkyl or 4-8 membered heterocyclyl, each of which is optionally substituted with from 1-3 substituents each independently selected from the group consisting of halo, cyano, C1-3 alkyl, C1-3 haloalkyl, —OH, C1-3 alkoxy, and C1-3 haloalkoxy.
61 more elements
A compound of Formula IIE:
- or a pharmaceutically acceptable salt, deuterated analog, or solvate thereof, wherein:
- Ring B is selected from the group consisting of:
- wherein bb represents the point of attachment to the —C(O)— and xx represents the point of attachment to Xb;
- R4, R5, R6, and R7 are independently selected from the group consisting of H, halo, and C1-6 alkyl;
- RAA, RAB, and RAC are each independently hydrogen, halo, C1-3 alkyl, or C3-6 cycloalkyl;
- R3 is H or C1-3 alkyl;
- RQC is H or halo;
- RQD is selected from the group consisting of:
- (a) H;
- (b) —NH2;
- (c) —NH(C1-3 alkyl);
- (d) halo;
- (e) C1-3 alkoxy optionally substituted with from 1-3 independently selected halo;
- and (f) C1-3 alkyl optionally substituted with from 1-3 independently selected halo;
- Ra and Rb are each independently selected from the group consisting of:
- C1-4 alkyl and C3-6 cycloalkyl;
- or
- Ra and Rb taken together with the phosphorous atom to which each is attached form a ring including from 5-8 ring atoms, wherein from 0-1 ring atom (in addition to the phosphorous attached to Ra and Rb) is a heteroatom independently selected from the group consisting of:
- O, S, and N;
- R8c is H or C1-3 alkyl;
- XB is CH or N;
- and
- each RCb is independently selected from the group consisting of H and C1-3 alkyl.
20 more elements
A compound selected from:
- or a pharmaceutically acceptable salt, deuterated analog, or solvate thereof.
Dependencies are inferred from the claim text.